Myrtelle, Inc.
  • About
    • Meet Our Team
  • Pipeline
    • Multiple System Atrophy
    • H-ABC
    • Pelizaeus Merzbacher Disease
    • DFNB-8
  • Technology
  • Clinical Trials
  • Canavan Disease
    • Canavan Treatment
  • News
  • Resources
  • Inquire

NEWS

  • Jordana Holovach (06.06.2023) 1 hour 17 minutes
  • (Events)

Watch Now: Myrtelle ASGCT Symposium Presentations

(Related Articles)

Jordana Holovach (05.13.2025) 3

(Canavan Disease)(Press Release)

Jordana Holovach (10.01.2024) 3

(Canavan Disease)(Press Release)

Jordana Holovach (06.05.2024)

(Press Release)

See More Articles
Learn More

Understanding Gene Therapy for Rare CNS Diseases

Download
(About the Author)

Jordana Holovach

Vice President, Head of Communications and Community

Jordana joined the Company in 2021, bringing more than 20 years of experience in leadership roles in the non-profit/rare disease sector.

Myrtelle, Inc.

    Join Our Community

    Sign up to receive Myrtelle news and updates.


    Contact

    781-621-2381

    info@myrtellegtx.com

    17 State Street
    Floor 3
    Suite 350
    New York, NY 10004

    Company

    • About
    • Team
    • Pipeline
    • Technology
    • Clinical Trials
    • News
    • Resources

    Indications

    • Canavan Disease
    • Pelizaeus Merzbacher Disease
    • H-ABC
    • MSA
    • DFNB-8 for Hearing Loss

    Myrtelle © 2024. All Rights Reserved. Privacy Policy. Designed by Barton Creative & Consulting. Developed by Emerald Digital.